291 search results for “cancer immunotherapie” in the Staff website
-
Peter BouwmanFaculty of Science
r.j.p.bouwman@lacdr.leidenuniv.nl | 071 5276105
-
Zebrafish against cancer
Valedictory lecture
-
'There's nothing more we can do for you' - New publication on harmful communication in oncology
PhD student Janine Westendorp and her colleagues conducted literature research on what patients with cancer and their loved ones perceive as harmful communication from healthcare providers. The results were published in the journal Psycho-Oncology and are released as a poster to distribute to healthcare…
-
Five Leiden contributions to NWO Perspectief projects
Five consortia within the Perspectief programme that include Leiden researchers have received funding to start their research projects. These projects focus on (further) developing technological innovations, with societal and economic impact at their core.
-
Chemotherapy without side effects? It’s possible, with light
Nausea, neurologic pain and hair loss: some of the severe side effects of chemotherapy. Not necessary, biochemist Liyan Zhang showed. Together with Leiden biologists and others, she achieved great results with a drug that is only active in combination with light. Zhang will defend her PhD on 4 July.
-
Tazuko van Berkel and Noel de Miranda join Young Academy
Leiden researchers Tazuko van Berkel (Greek and Latin Language and Culture) and Noel de Miranda (Tumour Immunology, LUMC) will join the KNAW’s Young Academy next year. They will be inducted on 22 March 2021.
-
Eleven Open Competition Domain Science XS grants for Leiden researchers
Eleven researchers from Leiden University have been awarded an Open Competition Domain Science ENW XS grant by the Dutch Research Council for their research projects. They are researching how to make software faster and greener, improve cancer detection and reduce anxiety by manipulating the biological…
-
How to develop cancer drugs with less side effects
Lecture, Tuesday Talks: Science Insights
-
A quick call with Corinda van Bohemen about the SteunLeiden.nl crowdfunding platform
From an emergency fund for Ukrainian students to a golf tournament for cancer research at the LUMC: the Leiden University Fund (LUF) crowdfunding platform is full of fantastic projects that enrich the university. If you are looking for funding for your idea or special project, crowdfunding may just…
-
Elizabeth (Liesbeth) de LangeFaculty of Science
ecmdelange@lacdr.leidenuniv.nl | +31 71 527 6330
-
Seven Leiden professors elected new members of KNAW
Seven Leiden professors have been elected as members of the Royal Netherlands Academy of Arts and Sciences (KNAW). In total 23 new members will be inaugurated on Monday 13 September.
-
Regulation of signal transduction pathways by hypoxia in breast cancer subtypes
PhD defence
-
Medical milestone at LUMC: first Dutch patient receives CAR T-cell therapy for autoimmune disease
The LUMC has become the first institution in the Netherlands to treat a patient with an autoimmune disease using CAR T-cell therapy.
-
‘Using real-world data to enhance our healthcare system’
On 16 May 2022, Professor Michel Wouters from the Department of Biomedical Data Sciences at the Leiden University Medical Centre (LUMC), will deliver his inaugural lecture titled ‘Quality of Cancer Care: why the real world matters’. Wouters will use the opportunity to describe how quality registries…
-
John HaanenFaculteit Geneeskunde
j.haanen@nki.nl | +31 71 526 3057
-
Rick HaasFaculteit Geneeskunde
r.l.m.haas@lumc.nl | +31 71 526 9111
-
Eveline BleikerFaculteit Geneeskunde
e.bleiker@nki.nl | +31 71 526 8033
-
Patient-derived models of breast cancer: A breakthrough story of the duct
PhD defence
-
Disrupting the transcriptional machinery to combat triple-negative breast cancer
PhD defence
-
BRCA1-associated breast cancer: finding new weapons for an old villain
PhD defence
-
Multifaceted Roles of Grainyhead-like Transcription Factor- 2 in Breast Cancer
PhD defence
-
From discovery to business: 'In the lab, we often don't realise that we are working to help an immense number of patients'
'It gave our team a big boost to hear that our work was valuable,' says medical chemist Elmer Maurits about the moment they won the Venture Challenge. With their company Iprotics, they want to develop a drug that can better treat patients with autoimmune diseases and blood cancers. 25,000 euros of prize…
-
James HardwickFaculteit Geneeskunde
j.c.h.hardwick@lumc.nl | +31 71 526 5364
-
Maarten VermeerFaculteit Geneeskunde
m.h.vermeer@lumc.nl | +31 71 526 1952
-
Life after the Grand Jamboree: Wrapping-up iGEM
‘A challenging rollercoaster, but also a very bonding and insightful experience,’ that’s how the team of iGEM Leiden 2022 wraps up their participation in the iGEM contest. The contest for synthetic biology climaxed during the Grand Jamboree in Paris. The team ended up in the top 10 of over 360 teams…
-
Leiden University honours Lex van der Eb with University Medal
Leiden University has awarded its prestigious University Medal to Emeritus Professor Lex van der Eb. As a pioneer in genetics and molecular biology, he received this honour for his services to science and his key role in the development of the Leiden Bio Science Park (LBSP).
-
Alfred VertegaalFaculteit Geneeskunde
vertegaal@lumc.nl | +31 71 526 9111
-
Marjanka SchmidtFaculteit Geneeskunde
m.k.schmidt@lumc.nl | +31 71 526 9111
-
Jeroen JansenFaculteit Geneeskunde
j.c.jansen@lumc.nl | +31 71 5 26 91 11
-
Chenlin FengFaculty of Science
c.feng@lacdr.leidenuniv.nl | 071 5272727
-
Daisy BatenburgFaculty of Science
d.batenburg@lacdr.leidenuniv.nl | 071 5272727
-
Andraniek EvadgianFaculty of Science
-
Medical Delta professor Marco van Vulpen: ‘I advocate the introduction of the share factor’
Proton therapy is a new way of treating cancer in which radiation doses are delivered more precisely. This results in less damage to surrounding tissue and fewer side effects. Professor Marco van Vulpen is medical director of HollandPTC in Delft, where the social value of this therapy is studied. Van…
-
New Year's Reception Faculty of Science
Conference
-
Mick van SchaickFaculty of Science
m.van.schaick@lacdr.leidenuniv.nl | 071 5272727
-
Joan Hendrik VeelkenFaculteit Geneeskunde
j.h.veelken@lumc.nl | +31 71 526 2267
-
Jelle WesselingFaculteit Geneeskunde
j.wesseling@nki.nl | +31 71 526 6622
-
Coen RaschFaculteit Geneeskunde
c.r.n.rasch@lumc.nl |
-
Johanneke PortieljeFaculteit Geneeskunde
j.e.a.portielje@lumc.nl | +31 71 526 3464
-
Monique van LeerdamFaculteit Geneeskunde
m.v.leerdam@nki.nl | +31 71 526 9111
-
J MorreauFaculteit Geneeskunde
j.morreau@lumc.nl | +31 71 526 6630
-
Hans GelderblomFaculteit Geneeskunde
a.j.gelderblom@lumc.nl | +31 71 526 3486
-
Karin de VisserFaculteit Geneeskunde
k.e.de_visser@lumc.nl |
-
Britt DuijndamFaculty of Science
b.h.a.duijndam@lacdr.leidenuniv.nl | +31 71 527 2727
-
Hans VasenFaculteit Geneeskunde
h.f.a.vasen@lumc.nl |
-
Rob PelgerFaculteit Geneeskunde
r.c.m.pelger@lumc.nl |
-
Klara BeslmüllerFaculty of Science
k.beslmuller@lacdr.leidenuniv.nl | 071 5272727
-
Jannie Keyser-BorstFaculteit Geneeskunde
j.g.borst@lumc.nl |
-
Michiel van de SandeFaculteit Geneeskunde
m.a.j.van_de_sande@lumc.nl | +31 71 526 3606
-
Thorbald van HallFaculteit Geneeskunde
t.van_hall@lumc.nl | +31 71 526 6945